Salvus Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,133
Closed -$270K 124
2024
Q4
$270K Buy
3,133
+69
+2% +$5.94K 0.17% 103
2024
Q3
$365K Buy
3,064
+198
+7% +$23.6K 0.22% 94
2024
Q2
$409K Buy
2,866
+220
+8% +$31.4K 0.28% 85
2024
Q1
$340K Buy
2,646
+416
+19% +$53.4K 0.23% 87
2023
Q4
$231K Buy
+2,230
New +$231K 0.16% 102